Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection

被引:169
作者
Melter, M
Exeni, A
Reinders, MEJ
Fang, JC
McMahon, G
Ganz, P
Hancock, WW
Briscoe, DM
机构
[1] Childrens Hosp, Div Nephrol, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pediat, Boston, MA USA
[3] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA
[4] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[5] Millennium Pharmaceut Inc, Cambridge, MA USA
关键词
transplantation; chemokine; rejection;
D O I
10.1161/hc4601.098010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Chemokines play an essential role in regulating the infiltration of leukocytes into allografts in experimental models. Little is known of their expression or function after human cardiac transplantation. Methods and Results-We analyzed 169 sequential human endomyocardial biopsies by immunocytochemistry for infiltration by CD3(+) T cells and the expression of the chemokine receptors CCR1, CCR3, CCR5, and CXCR3. In both cross-sectional and longitudinal analyses, the expression of each of the chemokine receptors correlated with the degree of CD3(+) T-cell infiltration. In particular, the expression of CXCR3 was temporally and spatially associated with CD3(+) T-cell infiltrates and correlated with the histopathological diagnosis of acute rejection (OR, 11.73 and 4.05, respectively; P <0.001). Of 7 patients followed up longitudinally for 1 year, 4 with consecutive biopsies developed intimal thickening by intravascular ultrasound. In these patients, there was a trend for persistent expression of CD3- and CXCR3-expressing infiltrates in the later part of the first posttransplant year. The chemokines eotaxin, IP-10, lymphotactin, MCP-1, Mig, RANTES, and SDF-1 were examined in an additional 35 biopsies by RT-PCR. Eotaxin, lymphotactin, MCP-1, mg, and SDF-1 were present in both normal and rejecting biopsies. However, the CXCR3 ligand IP-10, which was rarely expressed in normal biopsies, was markedly induced in acute rejection (OR, 19.43; P=0.01). Conclusions-The presence of CXCR3(+) T cells and the CXCR3 ligand IP-10 within endomyocardial biopsies is strongly associated with acute rejection. The CXCR3-IP-10 interaction warrants consideration as a therapeutic target in the management of cardiac allograft recipients.
引用
收藏
页码:2558 / 2564
页数:7
相关论文
共 22 条
[1]   ACTIVATION OF DUAL T-CELL SIGNALING PATHWAYS BY THE CHEMOKINE RANTES [J].
BACON, KB ;
PREMACK, BA ;
GARDNER, P ;
SCHALL, TJ .
SCIENCE, 1995, 269 (5231) :1727-1730
[2]  
Billingham M E, 1990, J Heart Transplant, V9, P587
[3]   PREDICTIVE VALUE OF INDUCIBLE ENDOTHELIAL-CELL ADHESION MOLECULE EXPRESSION FOR ACUTE REJECTION OF HUMAN CARDIAC ALLOGRAFTS [J].
BRISCOE, DM ;
YEUNG, AC ;
SCHOEN, EL ;
ALLRED, EN ;
STAVRAKIS, G ;
GANZ, P ;
COTRAN, RS ;
POBER, JS .
TRANSPLANTATION, 1995, 59 (02) :204-211
[4]   Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant [J].
Davis, SF ;
Yeung, AC ;
Meredith, IT ;
Charbonneau, F ;
Ganz, P ;
Selwyn, AP ;
Anderson, TJ .
CIRCULATION, 1996, 93 (03) :457-462
[5]  
Denton M D, 2000, Pediatr Transplant, V4, P252, DOI 10.1034/j.1399-3046.2000.00031.x
[6]   Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts [J].
Fairchild, RL ;
VanBuskirk, AM ;
Kondo, T ;
Wakely, ME ;
Orosz, CG .
TRANSPLANTATION, 1997, 63 (12) :1807-1812
[7]   Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection [J].
Gao, W ;
Topham, PS ;
King, JA ;
Smiley, ST ;
Csizmadia, V ;
Lu, B ;
Gerard, CJ ;
Hancock, WW .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (01) :35-44
[8]  
GAO W, IN PRESS TRANSPLANTA
[9]   Chemokines and their receptors in allograft rejection [J].
Hancock, WW ;
Gao, W ;
Faia, KL ;
Csizmadia, V .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (05) :511-516
[10]   Donor-derived IP-10 initiates development of acute allograft rejection [J].
Hancock, WW ;
Gao, W ;
Csizmadia, V ;
Faia, KL ;
Shemmeri, N ;
Luster, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (08) :975-980